Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
16.06B | 16.97B | 16.83B | 19.31B | 13.57B | Gross Profit |
8.00B | 8.47B | 9.37B | 11.60B | 7.57B | EBIT |
771.79M | 338.30M | 596.06M | 1.82B | 116.45M | EBITDA |
833.68M | 420.04M | 782.02M | 1.99B | 223.13M | Net Income Common Stockholders |
394.36M | 120.44M | 382.62M | 1.16B | 40.52M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.84B | 1.89B | 1.07B | 3.03B | -820.00M | Total Assets |
7.21B | 7.15B | 8.02B | 8.22B | 6.04B | Total Debt |
0.00 | 0.00 | 1.00B | 500.00M | 820.00M | Net Debt |
-1.75B | -1.89B | -70.30M | -2.53B | 1.64B | Total Liabilities |
1.64B | 1.85B | 2.75B | 3.08B | 820.00M | Stockholders Equity |
5.57B | 5.30B | 5.27B | 5.14B | 3.71B |
Cash Flow | Free Cash Flow | |||
106.09M | 1.84B | -2.04B | 2.19B | 757.91M | Operating Cash Flow |
264.00M | 2.04B | -1.92B | 2.37B | 932.20M | Investing Cash Flow |
-189.62M | -179.00M | -229.33M | -300.89M | -146.34M | Financing Cash Flow |
-234.86M | -1.10B | 258.04M | -269.25M | -496.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥10.65B | 15.69 | 1.18% | 15.20% | -17.04% | ||
75 Outperform | ¥14.67B | 24.25 | 0.82% | -5.08% | 198.67% | ||
67 Neutral | ¥10.21B | 8.35 | 0.35% | 8.04% | -19.57% | ||
66 Neutral | ¥11.87B | 12.45 | 3.60% | 4.17% | 28.46% | ||
63 Neutral | $6.96B | 11.51 | 2.80% | 3.85% | 2.70% | -24.43% | |
57 Neutral | ¥9.69B | ― | 4.67% | 8.47% | 85.95% | ||
42 Neutral | ¥8.19B | ― | ― | 2.96% | -119.07% |